GlassScriptPhysician profile
Timothy S Lyda
NPI 1952347106
$8,510.91
in general payments reported to CMS, 2019-2025
8 companies · $1,817 in 2025
The $1,817 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,198 · 2020: $1,025 · 2021: $706 · 2022: $1,127 · 2023: $1,209 · 2024: $1,428 · 2025: $1,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,454.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,466.74 | 2021-2025 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $1,699.04 | 2019-2020 | |
| Abbott Laboratories | $625.95 | 2019-2023 | Epic |
| Boston Scientific Corporation | $278.50 | 2019-2020 | |
| Davol INC. | $241.56 | 2022-2023 | Tridyne Vascular Sealant |
| Abiomed | $143.13 | 2025 | |
| Edwards Lifesciences Corporation | $35.93 | 2025 | Sapien 3 Ultra Resilia |
| Atricure, INC. | $20.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Lyda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.